[1]
F. Salazar-Onfray, “TRIMELVax: A Novel Innate Immune-Engaging Vaccine for Malignant Melanoma Targeting Neutrophil-Driven Antigen Presentation and T-Cell Activation”, SEE J Immunol, vol. 8, no. CITIM, p. 050, Mar. 2025.